Road to Offer
Road to Offer

Healthcare M&A Case Interview: Acquisition Analysis

Key facts for this case: type, industry, difficulty and firm style.
Case typeM&A
IndustryHealthcare / Digital Health
DifficultyMedium
Firm styleBCG
Practise this case liveWork it step by stepLearn how to solve it

The case prompt

Our client, HarborHealth, is a regional outpatient care network evaluating the acquisition of MedLink Virtual Care, a fast-growing telehealth provider. MedLink's shareholders are asking for an enterprise value of $420M. The CEO wants to know whether this deal should proceed and under what conditions it creates value.

HarborHealth operates 95 outpatient clinics across the U.S. Midwest and wants to expand into hybrid care models. MedLink provides virtual urgent-care visits and chronic-care monitoring, with a strong digital front-end but weaker payer contracting capabilities. Management believes there is strategic fit, but needs a clear view on valuation, realistic synergies, and integration risk before signing.

The exhibits

Exhibit 1

MedLink Financial Performance, 2022-2024 ($M)MedLink revenue, EBITDA, and EBITDA margin by year ($M), 2022-2024.

MedLink Financial Performance, 2022-2024 ($M)

MedLink revenue, EBITDA, and EBITDA margin by year ($M), 2022-2024.

Show the data behind Exhibit 1
MedLink Financial Performance, 2022-2024 ($M). MedLink revenue, EBITDA, and EBITDA margin by year ($M), 2022-2024.
YearRevenue ($M)EBITDA ($M)EBITDA Margin (%)
20221201210%
20231501812%
20241802514%

Exhibit 2

Trading Multiples vs Growth (Public Digital-Health Peers)EV/EBITDA multiple (x) vs revenue growth (%) for public digital-health peers and MedLink's asking valuation.

Trading Multiples vs Growth (Public Digital-Health Peers)

EV/EBITDA multiple (x) vs revenue growth (%) for public digital-health peers and MedLink's asking valuation.

Show the data behind Exhibit 2
Trading Multiples vs Growth (Public Digital-Health Peers). EV/EBITDA multiple (x) vs revenue growth (%) for public digital-health peers and MedLink's asking valuation.
CompanyRevenue Growth (%)EV/EBITDA (x)
Peer A911.0
Peer B1213.0
Peer C1414.0
Peer D1414.0
Peer E1715.5
Peer F1916.0
Peer Median1414.0
MedLink (asking)2016.8

Exhibit 3

Value Bridge to Maximum Justified Offer ($M)Value bridge from Standalone EV to Maximum Justified EV ($M), showing synergy value added and integration costs deducted.

Value Bridge to Maximum Justified Offer ($M)

Value bridge from Standalone EV to Maximum Justified EV ($M), showing synergy value added and integration costs deducted.

Show the data behind Exhibit 3
Value Bridge to Maximum Justified Offer ($M). Value bridge from Standalone EV to Maximum Justified EV ($M), showing synergy value added and integration costs deducted.
DriverAssumptionValue ($M)
Standalone EV2024 EBITDA $25M x 14.0x peer median350
Synergy ValueRun-rate synergies $18M x 70% capture x 10x multiple126
Integration CostsOne-time integration costs-45
Max Justified EV350 + 126 - 45431

Exhibit 4

Integration Risk Assessment (1=Low, 5=High)Integration Risk Assessment (1=Low, 5=High) chart with 5 data points

Integration Risk Assessment (1=Low, 5=High)

Show the data behind Exhibit 4
Integration Risk Assessment (1=Low, 5=High)
WorkstreamRisk Score (1-5)Primary Concern
Clinical Protocols2Different care pathways across virtual vs in-person teams
Provider Contracting3Payer renegotiation complexity
Tech Migration4Platform downtime and interoperability risk
Data Privacy Compliance5HIPAA compliance and cybersecurity exposure
Brand Harmonization3Patient confusion during transition
HarborHealth Acquisition of MedLink Virtual CareBCG

M&A · medium

HarborHealth Acquisition of MedLink Virtual Care

Healthcare / Digital Health

Practise this case free

How a strong candidate structures it

A strong M&A structure could cover four areas

01
1.Strategic Fit and Deal Rationale
a.Why this target vs build/partner alternatives
b.Capability complementarity (digital front-end + physical network)
c.Customer and market logic
02
1.Standalone Valuation and Price Discipline
a.Target financial quality (growth, margin trajectory)
b.Market benchmark multiples
c.Implied premium at asking price
03
1.Synergies and Value Creation
a.Credible cost and revenue synergy levers
b.Probability-adjusted capture and timing
c.Integration costs and net value creation
04
1.Integration Feasibility and Risk
a.Technology and data/privacy execution risk
b.Operating model and governance
c.Day-1 / Day-100 plan and deal guardrails

Question by question

  1. 1

    Case context

    Understand the Case

    “Could you briefly restate the client situation and the core decision we need to make?”

  2. 2

    Clarifying

    Clarifying Questions

    “What clarifying questions would you ask before building your approach?”

  3. 3

    Structure

    Framework

    “How would you structure your analysis for this M&A decision? Tell me where you would start your investigation and why.”

    Drill the structure
  4. 4

    Analysis

    Strategic Rationale Brainstorm

    “Before looking at detailed valuation math, brainstorm the main strategic reasons this deal could create value, and what you would test first.”

    Drill the brainstorming
  5. 5

    Math

    Valuation Benchmarking

    “Using Exhibits 1 and 2, what EV/EBITDA multiple is implied by the $420M asking price, and how does it compare with peers?”

    Drill the math
  6. 6

    Math

    Maximum Justified Offer

    “Now use Exhibit 3 to calculate the maximum justified enterprise value and whether paying $420M creates value in base case.”

    Drill the math
  7. 7

    Analysis

    Integration Risk and Guardrails

    “Using Exhibit 4, what are the top integration risks, and what guardrails would you set before closing?”

    Drill the brainstorming
  8. 8

    Synthesis

    Final Recommendation

    “What is your final recommendation to HarborHealth's CEO on this acquisition?”

    Drill the synthesis

The worked path

The numbers that decide it

  • MedLink grew revenue from $120M to $180M from 2022 to 2024, while EBITDA increased from $12M to $25M and margin improved from 10% to 14%.
  • Asking valuation implies 16.8x EV/EBITDA ($420M / $25M), above peer median of 14.0x.
  • Standalone fair value using peer median is about $350M (14.0x x $25M).
  • Base-case synergy value is $126M (run-rate $18M x 70% capture x 10x).
  • After $45M one-time integration costs, net synergy value is $81M.
  • Maximum justified enterprise value is about $431M, giving roughly $11M headroom versus the $420M ask.
  • Key downside risk is execution: data privacy and tech migration are the highest-risk workstreams.
  • Deal can be value-creating, but only with strict integration governance and price discipline.

Analysis Flow

  1. 1

    Start with deal framing

    • Confirm objective: decide whether to acquire MedLink at $420M and under what conditions.
    • Separate the problem into valuation, synergies, and integration feasibility.
  2. 2

    Assess standalone quality and valuation

    • Use Exhibit 1 to establish that MedLink has real growth and improving profitability.
    • Use Exhibit 2 to benchmark implied multiple: 16.8x vs ~14.0x median peers, indicating a meaningful premium.
  3. 3

    Quantify value creation

    Estimate standalone fair value: $25M EBITDA × 14.0x = $350M

    Add probability-adjusted synergy value from Exhibit 3: $126M

    Subtract one-time integration cost: $45M

    • Maximum justified EV: $431M, which is slightly above the $420M ask.
  4. 4

    Pressure-test execution risk

    • Use Exhibit 4 to identify concentration of risk in data/privacy and technology migration.
    • Conclude that value creation is possible, but sensitive to integration execution and synergy capture.
  5. 5

    Recommendation

    Proceed with acquisition only with clear deal guardrails

    • Do not exceed a total EV around $430M in base case
    • Launch a Day-1 to Day-100 integration office
    • Track synergy KPIs monthly with explicit owners
    • Set hard controls on data/privacy and platform migration readiness
  6. 6

    Risks and next steps

    • Risks: delayed tech migration, compliance issues, lower synergy capture.
    • Next steps: final diligence on tech architecture, compliance gap assessment, and synergy workplan validation before signing.

Final Synthesis

This deal is a conditional yes. At a $420M price, HarborHealth can create value in base case, but the margin of safety is narrow. Success depends on disciplined pricing and high-quality integration execution.

HarborHealth Acquisition of MedLink Virtual CareBCG

M&A · medium

HarborHealth Acquisition of MedLink Virtual Care

Healthcare / Digital Health

Practise this case free

Why this case

This scenario tests whether you can distinguish strategic fit from a price you can defend. Unlike a generic M&A case, it combines a digital front-end with a physical care network, so payer contracting, HIPAA exposure, technology migration, and clinical handoffs matter to value. The key trap is accepting a premium for growth without stress-testing synergy capture and integration governance. The case rewards a conditional recommendation, not reflexive yes or no.

FAQ

How do you value the target in this healthcare M&A case interview?
Start with MedLink’s standalone earnings, then benchmark the asking multiple against digital-health peers. Its 2024 EBITDA is $25M, and the peer median is 14.0x, implying standalone value of about $350M. Then add only credible, probability-adjusted synergies and subtract one-time integration costs before setting a maximum offer.
What makes the $420M offer acceptable?
The value bridge reaches a maximum justified enterprise value of $431M: $350M standalone value, plus $126M of synergy value, less $45M of integration costs. That leaves roughly $11M of headroom at the asking price. A strong recommendation still demands negotiation room and a hard ceiling because the margin of safety is narrow.
Which healthcare integration risks matter most?
Data privacy compliance is the highest-risk workstream, with a risk score of 5, followed by technology migration at 4. The practical concerns are HIPAA and cybersecurity exposure, plus platform downtime and interoperability. Set readiness gates, named owners, and phased migration milestones before closing or releasing any contingent consideration.
How should you structure the recommendation?
Use four lenses: strategic fit, standalone valuation, synergy value, and integration feasibility. Explain why buying the digital capability beats building or partnering, test whether the premium is supported, quantify net value after costs, and finish with deal guardrails. Recommend a conditional yes only if diligence confirms the technology and compliance plan.
HarborHealth Acquisition of MedLink Virtual CareBCG

M&A · medium

HarborHealth Acquisition of MedLink Virtual Care

Healthcare / Digital Health

Practise this case free